SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-003721
Filing Date
2024-02-14
Accepted
2024-02-14 16:15:21
Documents
1
Period of Report
2019-10-08

Document Format Files

Seq Description Document Type Size
1 form4a-02142024_040202.html 4/A  
1 form4a-02142024_040202.xml 4/A 4374
  Complete submission text file 0001415889-24-003721.txt   5667
Mailing Address
Business Address
LEVIN JEREMY M (Reporting) CIK: 0001256153 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38085 | Film No.: 24638383

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)